EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacological Gq targeting prevents asthmatic airway remodeling

Jennifer M Dietrich, Michaela Matthey, Annika Simon, Alexander Seidinger, Cynthia Koziol-White, Reynold A Panettieri, Bernd K Fleischmann, Daniela Wenzel

Molecular Therapy · 2025

DOI: 10.1016/j.ymthe.2025.07.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2025. Verfasst von Jennifer M Dietrich und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiology I, Life&Brain Center, Medical Faculty, University of Bonn, 53127 Bonn, Germany. Hauptthemen laut MEDLINE: Asthma, Airway Remodeling, GTP-Binding Protein alpha Subunits, Gq-G11. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Airway remodeling is a critical hallmark of chronic asthma that is very difficult to treat. We have investigated this pathological process and found that local application of the pharmacological Gq inhibitor FR900359 (FR) attenuates the main features of airway remodeling, namely collagen deposition and goblet cell metaplasia in the chronic ovalbumin-induced asthma model in mice. We have explored the molecular mechanisms underlying the FR action and demonstrate that FR mitigates the growth of human lung fibroblasts in response to pathological stimuli in vitro. Likewise, FR inhibits mucus production and secretion in air-liquid interface cultures of human bronchial epithelial cells and in a human lung mucoepidermoid cell line. Notably, FR blocks mucus secretion in human lung slices from asthmatic patients. Thus, Gq proteins play a critical role in airway remodeling, hence pharmacological inhibition of Gq signaling represents a promising strategy for the treatment of chronic asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaAirway RemodelingGTP-Binding Protein alpha Subunits, Gq-G11AnimalsHumansMiceDisease Models, AnimalOvalbuminFibroblastsLungCell LineMucusGoblet CellsSignal Transduction

Stichwörter der Autor:innen

Gq proteinsairway remodelingasthmagoblet cell metaplasiamucus production

Substanzen

GTP-Binding Protein alpha Subunits, Gq-G11Ovalbumin

Autor:innen und Institutionen

  • Institute of Physiology I, Life&Brain Center, Medical Faculty, University of Bonn, 53127 Bonn, Germany.
  • Institute of Physiology, Department of Systems Physiology, Medical Faculty, Ruhr University of Bochum, 44801 Bochum, Germany.
  • Rutgers Institute for Translational Medicine and Science, The State University of New Jersey, Rutgers, New Brunswick, NJ08901, USA.
  • Institute of Physiology, Department of Systems Physiology, Medical Faculty, Ruhr University of Bochum, 44801 Bochum, Germany; Institute of Physiology I, Life&Brain Center, Medical Faculty, University of Bonn, 53127 Bonn…

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Dietrich, J. M., Matthey, M., Simon, A., Seidinger, A., Koziol-White, C., Panettieri, R. A., Fleischmann, B. K., & Wenzel, D. (2025). Pharmacological Gq targeting prevents asthmatic airway remodeling. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2025.07.032

Vancouver

Dietrich JM, Matthey M, Simon A, Seidinger A, Koziol-White C, Panettieri RA, et al. Pharmacological Gq targeting prevents asthmatic airway remodeling. Molecular Therapy. 2025. doi:10.1016/j.ymthe.2025.07.032

BibTeX
@article{Dietrich2025,
  author = {Dietrich, Jennifer M and Matthey, Michaela and Simon, Annika and Seidinger, Alexander and Koziol-White, Cynthia and Panettieri, Reynold A and Fleischmann, Bernd K and Wenzel, Daniela},
  title = {Pharmacological Gq targeting prevents asthmatic airway remodeling},
  journal = {Molecular Therapy},
  year = {2025},
  doi = {10.1016/j.ymthe.2025.07.032}
}
Kostenlos starten →